Press Releases Jacobson Pharma Corporation Limited

Equities

2633

KYG677291067

Market Closed - Hong Kong S.E. Other stock markets 01:38:22 10/05/2024 pm IST			5-day change	1st Jan Change
0.6 ^HKD	+1.69%		+5.26%	-6.25%

27/02	Jacobson Pharma Raises HK$39 Million from Share Placement	MT
2023	Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jacobson Pharma : 2023 Environmental, Social and Governance Report	07/23/07	PU
Jacobson Pharma : 2023 Annual Report	07/23/07	PU
Jacobson Pharma : 2022 Interim Report	09/22/09	PU
Jacobson Pharma Announces FY2023 Interim Results	25/22/25	AQ
Jacobson Pharma : 2022 Annual Report	21/22/21	PU
Jacobson Pharma Announces FY2022 Annual Results	29/22/29	AQ
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia	15/22/15	AQ
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60%	14/22/14	AQ
Jacobson Pharma : 2021 Interim Report	10/21/10	PU
Jacobson Pharma Announces FY2022 Interim Results	26/21/26	AQ
Jacobson Pharma : Announces FY2021 Annual Results	29/21/29	AQ
Jacobson Pharma : CHANGE OF COMPANY SECRETARY	01/21/01	PU
Jacobson Pharma : JBM (Healthcare) Limited to Be Spun Off from Jacobson Pharma Corporation Limited	25/21/25	AQ
Jacobson Pharma : Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited	15/21/15	AQ
Jacobson Pharma : Announces FY2021 Interim Results	27/20/27	AQ
Jacobson Pharma : Submits Form A1 to Spin-off Its Branded Healthcare Business	23/20/23	AQ
Jacobson Pharma : PROPOSED SPIN-OFF AND SEPARATE LISTING OF JBM (HEALTHCARE) LIMITED ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED	23/20/23	PU
Jacobson Pharma : POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON WEDNESDAY, 23 SEPTEMBER 2020	23/20/23	PU
BioNTech : and Fosun Pharma to Potentially Supply 10 Million Doses of BioNTech's BNT162 mRNA-based Vaccine Candidate Against SARS-CoV-2 to Hong Kong SAR and Macao SAR	28/20/28	AQ
Jacobson Pharma : Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SE's COVID-19 Vaccine Candidate in Hong Kong and Macau	27/20/27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Jacobson Pharma Corporation Limited

Equities

2633

KYG677291067

Press Releases

Filters